• Stoke Therapeutics highlights antisense pipeline as genetic medicine interest grows Ad-hoc-news.de Wed, 08 Jul 2026 17:34:39 GMT
• How Investors May Respond To Stoke Therapeutics (STOK) Completing Phase 3 Enrollment For Zorevunersen In Dravet Syndrome simplywall.st Wed, 08 Jul 2026 00:45:00 GMT
• Stoke Therapeutics holds the focus. Investors await the next evidence Ad-hoc-news.de Tue, 07 Jul 2026 14:59:02 GMT
• Moran Wealth Management LLC Takes $1.32 Million Position in Stoke Therapeutics, Inc. $STOK MarketBeat Tue, 07 Jul 2026 14:43:20 GMT
• Stoke Therapeutics (STOK) CMO sells 7,228 shares in planned 10b5-1 trades Stock Titan Mon, 06 Jul 2026 20:11:34 GMT
• Stoke Therapeutics outlines its antisense strategy as a rare disease player Ad-hoc-news.de Fri, 03 Jul 2026 15:21:28 GMT
• Stoke Therapeutics (STOK) Receives a Buy from Jefferies The Globe and Mail Thu, 02 Jul 2026 16:18:00 GMT
• STOK (NASDAQ) lists 7,228 RSUs and reports two 10b5-1 sales Stock Titan Wed, 01 Jul 2026 20:52:07 GMT
• Stoke Therapeutics Advances Zorevunersen in Dravet Syndrome Stud GuruFocus Tue, 30 Jun 2026 14:28:47 GMT
• Stoke Therapeutics (STOK) Advances Phase 3 Study and NDA Plans GuruFocus Tue, 30 Jun 2026 13:44:26 GMT
• Stoke completes phase 3 enrollment for Dravet syndrome drug By Investing.com Investing.com Canada Tue, 30 Jun 2026 12:39:23 GMT
• Stoke Therapeutics completes enrollment of 162 patients in Phase 3 EMPEROR; Q3 2027 readout, rolling NDA in 2027 TradingView Tue, 30 Jun 2026 12:03:01 GMT
• Stoke Therapeutics (NASDAQ: STOK) completes Phase 3 Dravet trial enrollment, targets 2027 NDA Stock Titan Tue, 30 Jun 2026 12:02:35 GMT
• Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investiga... Yahoo Finance Tue, 30 Jun 2026 12:00:00 GMT
• STOK Q1 2026 Earnings: Narrower-than-expected loss as Stoke Therapeutics advances pipeline - Post-Earnings Drift dars.gov.et Tue, 30 Jun 2026 08:37:43 GMT
• dravet syndrome foundation (dsf) announces 2026 community award winners EIN Presswire Mon, 29 Jun 2026 12:00:00 GMT
• Stoke Therapeutics, Inc.(NasdaqGS: STOK) dropped from Russell 3000E Index marketscreener.com Mon, 29 Jun 2026 04:28:41 GMT
• Does Broad Russell Index Removal Reshape the Bull Case for Stoke Therapeutics (STOK)? simplywall.st Mon, 29 Jun 2026 03:53:59 GMT
• Stoke Therapeutics, Inc.(NasdaqGS:STOK) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Assenagon Asset Management S.A. Sells 320,708 Shares of Stoke Therapeutics, Inc. $STOK MarketBeat Sat, 27 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 05:31:18 GMT
• price to sales forward of stoke therapeutics, inc. – nasdaq:stok TradingView Fri, 26 Jun 2026 21:06:25 GMT
• is stoke therapeutics (stok) undervalued or is future growth already priced in? simplywall.st Fri, 26 Jun 2026 20:39:08 GMT
• stoke therapeutics, inc. actuals & estimates (nasdaq:stok) TradingView Fri, 26 Jun 2026 05:52:43 GMT
• Enterprise value to EBITDA forward of Stoke Therapeutics, Inc. – NASDAQ:STOK TradingView Thu, 25 Jun 2026 14:17:37 GMT
• enterprise value to revenue forward of stoke therapeutics, inc. – gettex:0gt TradingView Thu, 25 Jun 2026 14:15:09 GMT
• stoke therapeutics inc (stok) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Stoke Therapeutics (STOK) Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary Quartr Sun, 21 Jun 2026 03:07:46 GMT
• stoke therapeutics stock - long-term strategy and genetic medicine pipeline AD HOC NEWS Sat, 20 Jun 2026 18:08:30 GMT
• Understanding the Setup: (STOK) and Scalable Risk Stock Traders Daily Fri, 19 Jun 2026 16:06:02 GMT
• stoke therapeutics general counsel sells $43,637 in common stock by investing.com Investing.com Canada Fri, 19 Jun 2026 06:07:26 GMT
• insider sell alert: jonathan allan sells shares of stoke therape GuruFocus Thu, 18 Jun 2026 22:39:37 GMT
• Stoke Therapeutics (STOK) legal chief sells 1,457 shares under 10b5-1 plan Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• stoke therapeutics general counsel sells $43,637 in common stock by investing.com Investing.com UK Thu, 18 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:54:29 GMT
• stoke therapeutics inc (stok) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 18:54:22 GMT
• stoke therapeutics inc (stok) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 18:25:50 GMT
• Stoke Therapeutics Inc (STOK) Valuation: PE, PB & Fair Value Analysis TradingKey Wed, 17 Jun 2026 18:20:06 GMT
• stoke therapeutics inc (stok) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 18:17:04 GMT
• stoke therapeutics inc (stok) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 15:38:17 GMT
• stoke therapeutics inc (stok) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 14:24:04 GMT
• stoke therapeutics inc (stok) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 14:23:21 GMT
• Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - June 16, 2026 BioSpace Wed, 17 Jun 2026 07:00:00 GMT
• granahan investment management llc has $6.08 million stock position in stoke therapeutics, inc. $stok MarketBeat Wed, 17 Jun 2026 07:00:00 GMT
• stoke therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) Business Wire Tue, 16 Jun 2026 07:00:00 GMT
• insider sales at stok (nasdaq: stok) list 27,481 shares in march 2026 Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• stoke therapeutics stock (us86150r1023): analyst sentiment and valuation come into focus AD HOC NEWS Mon, 15 Jun 2026 12:20:08 GMT
• Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts MarketBeat Mon, 15 Jun 2026 07:00:00 GMT
• stoke therapeutics inc (stok) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• rhenman & partners asset management ab lowers position in stoke therapeutics, inc. $stok MarketBeat Sat, 13 Jun 2026 09:53:57 GMT
• stoke therapeutics (nasdaq:stok) trading up 1.6% - should you buy? MarketBeat Sat, 13 Jun 2026 04:46:39 GMT
• stoke therapeutics (nasdaq:stok) trading up 1.6% - should you buy? MarketBeat Fri, 12 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Mon, 08 Jun 2026 16:19:04 GMT
• the technical signals behind (stok) that institutions follow Stock Traders Daily Mon, 08 Jun 2026 14:58:02 GMT
• stok: durable efficacy and cognitive gains position zorevunersen for a focused u.s. launch by 2028 TradingView Mon, 08 Jun 2026 07:00:00 GMT
• assessing stoke therapeutics (stok) valuation after recent share price cooling simplywall.st Sat, 06 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) forms 'hammer chart pattern': time for bottom fishing? MSN Fri, 05 Jun 2026 11:02:10 GMT
• [Form 4] Stoke Therapeutics, Inc. Insider Trading Activity Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) gets a buy from leerink partners The Globe and Mail Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) director granted 17,786 stock options at $29.46 Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) director receives grant of 17,786 stock options Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) director granted options to buy 17,786 shares Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) director awarded 17,786 options at $29.46 strike Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• stoke therapeutics (nasdaq: stok) 2026 meeting elects all directors Stock Titan Thu, 04 Jun 2026 20:08:29 GMT
• stok: lead therapy delivers durable seizure and cognitive benefits, with pivotal data due mid-2027 TradingView Thu, 04 Jun 2026 14:19:38 GMT
• Stoke Therapeutics (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? Zacks Investment Research Thu, 04 Jun 2026 07:00:00 GMT
• insider sell alert: barry ticho sells shares of stoke therapeutics inc (stok) GuruFocus Thu, 04 Jun 2026 03:08:41 GMT
• Stoke Therapeutics Inc Annual Shareholders Meeting Transcript GuruFocus Wed, 03 Jun 2026 07:00:00 GMT
• Insider Sell Alert: Barry Ticho Sells Shares of Stoke Therapeuti GuruFocus Wed, 03 Jun 2026 07:00:00 GMT
• stoke therapeutics (stok) cmo sells 1,795 shares under 10b5-1 plan Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• the bull case for stoke therapeutics (stok) could change following long-term zorevunersen data and phase 3 plans simplywall.st Tue, 02 Jun 2026 07:00:00 GMT
• Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates Insider Monkey Mon, 01 Jun 2026 07:00:00 GMT
• a look at stoke therapeutics (stok) valuation after mixed returns and premium p/b multiple simplywall.st Fri, 29 May 2026 06:19:01 GMT
• Stoke Therapeutics to Present at Upcoming Investor Conferences in June Business Wire Thu, 28 May 2026 07:00:00 GMT
• stoke therapeutics ceo to appear at jefferies and goldman sachs events Stock Titan Thu, 28 May 2026 07:00:00 GMT
• precision trading with stoke therapeutics inc. (stok) risk zones Stock Traders Daily Thu, 28 May 2026 07:00:00 GMT
• stoke therapeutics stock (us86150r1023): focus on genetic medicines after q1 update AD HOC NEWS Tue, 26 May 2026 11:04:52 GMT
• ubs group ag decreases stock position in stoke therapeutics, inc. $stok MarketBeat Fri, 22 May 2026 07:00:00 GMT
• Nathan Lee Starts New Role as Vice President, Commercial Manufacturing at Stoke Therapeutics hrtoday.in Fri, 22 May 2026 03:38:24 GMT
• Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? Eastern Progress Thu, 21 May 2026 07:00:00 GMT
• stoke therapeutics (stok) is down 7.8% after sharp q1 swing from profit to loss – what's changed Sahm Wed, 20 May 2026 07:00:00 GMT
• Zorevunersen tied to long-term benefits in Dravet syndrome Dravet Syndrome News Tue, 19 May 2026 07:00:00 GMT
• stoke therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) - may 18, 2026 BioSpace Tue, 19 May 2026 02:31:58 GMT
• lynx1 (stok) files 13g/a reporting 4.76m shares, 8.1% stake Stock Titan Tue, 19 May 2026 01:39:07 GMT
• stoke therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) Business Wire Mon, 18 May 2026 07:00:00 GMT
• lynx1 (stok) files 13g/a reporting 4.76m shares, 8.1% stake Stock Titan Mon, 18 May 2026 07:00:00 GMT
• technical reactions to stok trends in macro strategies Stock Traders Daily Sun, 17 May 2026 12:20:01 GMT
• stoke therapeutics stock (us86150r1023): fresh data in rare disease pipeline keeps investors watchin AD HOC NEWS Sun, 17 May 2026 07:04:15 GMT
• stoke therapeutics inc at td cowen healthcare conference transcript GuruFocus Sat, 16 May 2026 21:47:44 GMT
• stoke therapeutics (stok): analyst ratings and price target upda GuruFocus Sat, 16 May 2026 05:19:23 GMT
• rtw funds and r. wong report 9.99% stake in stoke therapeutics (stok) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• redmile group reports 4.16m shares in stoke therapeutics (stok) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lynx1 capital discloses 4.12m shares of stoke therapeutics (stok) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• wellington affiliates hold 3.1m shares in stoke therapeutics (stok) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• we're not very worried about stoke therapeutics' (nasdaq:stok) cash burn rate Moomoo Thu, 14 May 2026 07:00:00 GMT
• stoke outlines q1 2027 rolling nda start as emperor enrollment targets june, backed by $411m cash balance MSN Tue, 12 May 2026 12:03:14 GMT
• analysts offer insights on healthcare companies: stoke therapeutics (stok) and progyny (pgny) The Globe and Mail Tue, 12 May 2026 07:00:00 GMT
• stok reiterates by btig -- price target maintained at $39.00 GuruFocus Mon, 11 May 2026 11:48:45 GMT
• btig maintains stoke therapeutics(stok.us) with buy rating, maintains target price $39 富途牛牛 Mon, 11 May 2026 10:33:00 GMT
• Stoke Therapeutics, Inc. (NASDAQ:STOK) Analysts Are Pretty Bullish On The Stock After Recent Results Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• stoke therapeutics, inc. 2026 q1 - results - earnings call presentation (nasdaq:stok) 2026-05-11 Seeking Alpha Mon, 11 May 2026 07:00:00 GMT
• stoke therapeutics' (stok) "buy" rating reiterated at btig research MarketBeat Mon, 11 May 2026 07:00:00 GMT
• did stoke therapeutics’ q1 profit-to-loss swing and insider sale just shift stok’s investment narrative? Sahm Sun, 10 May 2026 20:13:16 GMT
• analyst reiterates buy on stoke therapeutics, maintains $40 price target on robust dravet data and phase 3 progress TipRanks Sat, 09 May 2026 09:14:50 GMT
• analysts offer insights on healthcare companies: definium therapeutics (dftx), guardant health (gh) and stoke therapeutics (stok) The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
• a quick look at today's ratings for stoke therapeutics(stok.us), with a forecast between $38 to $60 富途牛牛 Sat, 09 May 2026 07:00:00 GMT
• did stoke therapeutics’ q1 profit-to-loss swing and insider sale just shift stok’s investment narrative? simplywall.st Sat, 09 May 2026 07:00:00 GMT
• stoke therapeutics: buy rating reiterated as phase 3 dravet program advances; $60 price target maintained TipRanks Fri, 08 May 2026 22:06:56 GMT
• guggenheim maintains stoke therapeutics(stok.us) with buy rating, maintains target price $60 Moomoo Fri, 08 May 2026 11:36:00 GMT
• stoke therapeutics announces first quarter 2026 financial results and provides business updates BioSpace Fri, 08 May 2026 07:18:52 GMT
• stoke therapeutics (nasdaq:stok) announces earnings results, beats estimates by $0.01 eps MarketBeat Fri, 08 May 2026 07:00:00 GMT
• analyst reiterates buy on stoke therapeutics, maintains $40 price target on robust dravet data and phase 3 progress TipRanks Fri, 08 May 2026 07:00:00 GMT
• earnings call transcript: stoke therapeutics q1 2026 results show mixed performance Investing.com India Fri, 08 May 2026 07:00:00 GMT
• transcript : stoke therapeutics, inc., q1 2026 earnings call, may 07, 2026 marketscreener.com Fri, 08 May 2026 06:20:33 GMT
• stoke therapeutics q1 2026 slides show zorevunersen phase 3 progress Investing.com Fri, 08 May 2026 03:24:35 GMT
• stoke therapeutics (nasdaq:stok) beats q1 2026 estimates as phase 3 trial nears completion ChartMill Thu, 07 May 2026 23:29:56 GMT
• stoke therapeutics faces earnings test after revenue miss by investing.com Investing.com Nigeria Thu, 07 May 2026 17:04:52 GMT
• Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates Business Wire Thu, 07 May 2026 07:00:00 GMT
• Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• Stoke Therapeutics Q1 2026 slides show zorevunersen Phase 3 progress Investing.com Thu, 07 May 2026 07:00:00 GMT
• stoke therapeutics (nasdaq: stok) q1 2026 loss, zorevunersen data and cash runway to 2028 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• earnings call transcript: stoke therapeutics q1 2026 results show mixed performance Investing.com Thu, 07 May 2026 07:00:00 GMT
• stoke therapeutics (nasdaq: stok) swings to q1 2026 loss as biogen upfront revenue rolls off Stock Titan Thu, 07 May 2026 07:00:00 GMT
• earnings flash (stok) stoke therapeutics, inc. reports q1 revenue $6.2m, vs. factset est of $6.5m marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• trading the move, not the narrative: (stok) edition Stock Traders Daily Wed, 06 May 2026 11:12:01 GMT
Stoke Therapeutics, Inc(NASDAQ:STOK) 
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentat...
Website: http://www.stoketherapeutics.com
Founded: 2015
IPO Price: $18 (Jun 19, 2019)
Full Time Employees: 56
CEO: Edward M. Kaye
Sector: Healthcare
Industry: Biotechnology